SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (1575)6/23/2005 2:14:01 PM
From: w2004   of 1826
 
Erik,

Thanks for your input. This board has not had much discussion for the past year, however, I find that the info posted here is very good.

My concern is the Baird 2005 earnings estimate of $0.51 is very low -- Q1 was 0.15 so there thinking that Q2 will be bellow 0.10? That would be a big miss.

I agree that Dacogen will be a good boost, however, investors don't seem to value an NDA until after the FDA okay. I'm wondering where the stock will end up after July 13?

Also wondering where Richard has gone. During the last MGI investor presentation on June 6th, I believe the presenter stated MGI will be providing IRO 'positive' interim results at the 2Q earnings release.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News